Lorna McLeod

Latest from Lorna McLeod

Special Report on Process- and Product-Related Impurities (A CMC Strategy Forum Special Focus Series): Extractables, Leachables, Particles, and
CMC Forums
Special Report on Process- and Product-Related Impurities (A CMC Strategy Forum Special Focus Series): Extractables, Leachables, Particles, and AggregatesSpecial Report on Process- and Product-Related Impurities (A CMC Strategy Forum Special Focus Series): Extractables, Leachables, Particles, and Aggregates
byAnthony Mire-Sluis, Stacey Maand 3 more
Nov 17, 2016
Uniting Small-Molecule and Biologic Drug Perspectives: Analytical Characterization and Regulatory Considerations for Antibody–Drug Conjugates
Emerging Therapeutics
Uniting Small-Molecule and Biologic Drug Perspectives: Analytical Characterization and Regulatory Considerations for Antibody–Drug ConjugatesUniting Small-Molecule and Biologic Drug Perspectives: Analytical Characterization and Regulatory Considerations for Antibody–Drug Conjugates
byLorna McLeod, Jon Harrisand 4 more
Sep 23, 2015

All from Lorna McLeod

Glycosylation of Therapeutic Proteins: Current Understanding of Structure–Function Relationships logo in a gray background | Glycosylation of Therapeutic Proteins: Current Understanding of Structure–Function Relationships
Product Characterization
Glycosylation of Therapeutic Proteins: Current Understanding of Structure–Function Relationships
Glycosylation of Therapeutic Proteins: Current Understanding of Structure–Function Relationships
Sep 23, 2015
+4
byJoseph Siemiatkoski, Stacey Maand 4 more
Raw Material Control Strategies for Bioprocesses logo in a gray background | Raw Material Control Strategies for Bioprocesses
CMC Forums
Raw Material Control Strategies for Bioprocesses
Raw Material Control Strategies for Bioprocesses
Apr 14, 2015
+5
byGregory Beck, Mark Schenermanand 5 more
Multiproduct Facility Design and Control for Biologics: Challenges and Considerations logo in a gray background | Multiproduct Facility Design and Control for Biologics: Challenges and Considerations
CMC Forums
Multiproduct Facility Design and Control for Biologics: Challenges and Considerations
Multiproduct Facility Design and Control for Biologics: Challenges and Considerations
Apr 14, 2015
+7
byBo Chi, Julia Edwardsand 7 more
QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program logo in a gray background | QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program
Process Development
QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program
QbD for Biologics: Learning from the Product Development and Realization (A-MAb) Case Study and the FDA OBP Pilot Program
Sep 1, 2012
+8
bySteve Kozlowski, Wassim Nashabehand 8 more
From Pandemics to Bioterrorism logo in a gray background | From Pandemics to Bioterrorism
Economics
From Pandemics to Bioterrorism
From Pandemics to Bioterrorism
Jun 1, 2008
byLorna McLeod

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Register Now: Advanced CLD with S-CHOice®: Higher Productivity with Transposase Technology and Improved ADCC with S-AfuCHO™
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024